查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612720

CT/NG 檢測市場：按產品類型、技術和最終用戶分類 - 2025-2030 年全球預測

CT/NG Testing Market by Product (Assays & Kits, Instruments & Analyzers), Testing Type (Lab Tests, PoC Tests), Technology, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年CT/NG檢測市場價值為16.3億美元，預計到2024年將達到17.4億美元，複合年成長率為7.41%，預計到2030年將達到26.9億美元。

由於STD發生率上升和公眾健康意識的提高，包括沙眼衣原體和淋病奈瑟菌篩檢在內的CT/NG檢測披衣菌感染成為人們關注的焦點。這些細菌感染疾病的檢測極為重要，因為未經治療的感染疾病可能會導致嚴重的生殖健康問題。 CT/NG檢測的需求源於其在早期診斷和預防中的重要性，這對降低醫療成本和促進公共衛生安全有直接影響。這些測試主要應用於醫院、診所和診斷實驗室，適合性活躍的人，並且由於隱私和便利因素，擴大在家庭檢測套組中採用。分子診斷技術進步、政府健康措施以及對綜合性健康產品不斷成長的需求極大地推動了市場成長。主要成長機會集中在開發具有成本效益且高度靈敏的就地檢驗設備。從區域來看，由於醫療基礎設施的改善和疾病意識宣傳活動的加強，新興國家提供了巨大的成長機會。然而，先進檢測技術的高成本以及與性病檢測相關的社會文化恥辱等因素可能會阻礙成長並阻礙在保守地區的廣泛採用。技術創新的前景在於透過生物技術的進步加強快速檢測方法、提高檢測精度並降低成本。此外，將人工智慧和機器學習納入診斷過程有可能提高臨床環境中的資料準確性和業務效率，從而徹底改變市場交付。透過與醫療保健提供者和技術公司的策略合作，公司可以從擴大服務欠缺地區的訪問和可見性中受益。由於不斷變化的醫療保健優先事項和技術進步所驅動的市場動態具有動態性，因此持續的市場研究對於利用新機會和克服固有挑戰至關重要。

主要市場統計
基準年[2023] 16.3億美元
預計年份 [2024] 17.4億美元
預測年份 [2030] 26.9億美元
複合年成長率（%） 7.41%

市場動態：快速發展的 CT/NG 檢測市場的關鍵市場洞察

CT/NG 檢測市場正因供需的動態互動而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球性傳染感染流行率不斷上升
    • 提高對未經治療的感染疾病後果的認知
    • 對照護現場(POC) 測試設備的需求不斷成長
  • 市場限制因素
    • 與先進診斷設備相關的高成本
  • 市場機會
    • 政府推動性健康教育的舉措
    • 整合自動化系統以提高工作流程效率
  • 市場挑戰
    • 透過 CT/NG 檢測發現抗生素抗藥性菌株

波特五力：駕馭 CT/NG 檢測市場的策略工具

波特五力框架是了解 CT/NG 偵測市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對CT/NG檢測市場的影響

外部宏觀環境因素在塑造CT/NG檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解CT/NG檢測市場的競爭狀況

CT/NG 測試市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣CT/NG檢查市場供應商績效評估

FPNV定位矩陣是評估CT/NG檢查市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪 CT/NG 檢測市場的成功之路

CT/NG 檢測市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球性行為感染傳染病的盛行率不斷上升
      • 提高對未經治療的感染疾病影響的認知
      • 對照護現場(POC) 測試設備的需求不斷成長
    • 抑制因素
      • 與先進診斷設備相關的高成本
    • 機會
      • 政府推動性教育的努力
      • 整合自動化系統以提高工作流程效率
    • 任務
      • 透過 CT/NG 檢測發現抗生素抗藥性細菌
  • 市場區隔分析
    • 產品：快速部署儀器和分析儀以提供一致的結果
    • 測試類型：CT/NG PoC測試越來越流行
    • 技術：基於聚合酵素鏈鎖反應(PCR) 的 CT/NG 測試的發展，將準確性置於成本和速度之上
    • 最終使用者：醫院和診所就地檢驗的普及
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 CT/NG 檢查市場：依產品分類

  • 檢測方法和套件
  • 測量設備和分析設備

第7章 按測試類型分類的 CT/NG 檢查市場

  • 實驗室篩檢
  • 概念驗證測試

第8章 CT/NG 檢查市場：依技術分類

  • 免疫診斷
  • 恒溫核酸增幅技術
  • 聚合酵素鏈鎖反應

第 9 章 CT/NG 檢查市場：依最終使用者分類

  • 臨床實驗室
  • 醫院/診所

第10章 北美、南美CT/NG檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區CT/NG檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲CT/NG檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • binx health 宣布與 Afaxys 達成策略性供應協議，將性健康檢測範圍擴大到全國數千家診所。
    • Bio-Rad 推出 Exact Diagnostics CT/NG 和 STI 運作控制
    • 雅培 (Abbott) 獲得 FDA 批准，可在性行為感染病例上升的情況下同時檢測四種常見性性行為感染
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Binx Health, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group SAS
  • F. Hoffmann-La Roche Ltd.
  • Geneproof AS
  • Genetic Signatures Ltd.
  • Goffin Molecular Technologies BV
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Microbiologics, Inc.
  • Molbio Diagnostics Pvt. Ltd.
  • Operon SA
  • PerkinElmer Inc.
  • QIAGEN NV
  • Sansure Biotech Inc.
  • Seegene, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tianlong Technology Co., Ltd.
  • Vircell SL
  • Visby Medical, Inc.
Product Code: MRR-777F3B3232BF

The CT/NG Testing Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.74 billion in 2024, and is projected to grow at a CAGR of 7.41%, to USD 2.69 billion by 2030.

The CT/NG testing market, encompassing Chlamydia trachomatis and Neisseria gonorrhoeae screening, has gained prominence due to rising STD incidences and heightened public health awareness. These bacterial infections are crucial testing targets as untreated infections can lead to severe reproductive health issues. The necessity of CT/NG testing stems from its significance in early diagnosis and prevention, directly influencing healthcare cost reductions and promoting public health safety. Predominantly applied in hospitals, clinics, and diagnostic labs, these tests cater to sexually active populations, with increasing adoption in home-testing kits due to privacy and convenience factors. Market growth is significantly fueled by technological advancements in molecular diagnostics, governmental health initiatives, and rising demand for comprehensive sexual health products. Key growth opportunities are centered around the development of cost-effective and highly sensitive point-of-care testing devices. Delving into regional perspectives, developing countries offer substantial growth windows due to emerging healthcare infrastructures and increasing disease awareness campaigns. However, growth is challenged by factors like high costs of advanced testing technologies and socio-cultural stigmas associated with STD testing, potentially hindering widespread acceptance in conservative regions. Innovation prospects lie in the enhancement of rapid testing methods, improving detection accuracy, and cost reductions through biotechnology advancements. Furthermore, integrating artificial intelligence and machine learning in diagnostic processes may revolutionize market offerings by improving data accuracy and operational efficiencies in clinical settings. Businesses can benefit from strategic collaborations with healthcare providers and technology firms to expand access and awareness across under-penetrated regions. The CT/NG testing market is underlined by its dynamic nature, dictated by shifting healthcare priorities and technological progression, making continual market research and innovation essential for capitalizing on emerging opportunities and overcoming inherent challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.74 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 7.41%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving CT/NG Testing Market

The CT/NG Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of STIs worldwide
    • Growing awareness about the consequences of untreated infections
    • Rising need for point-of-care (POC) testing devices
  • Market Restraints
    • High costs associated with advanced diagnostic equipment
  • Market Opportunities
    • Government initiatives for promoting sexual health education
    • Integration of automation systems to enhance workflow efficiency
  • Market Challenges
    • Emergence of antibiotic-resistant strains by CT/NG testing

Porter's Five Forces: A Strategic Tool for Navigating the CT/NG Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the CT/NG Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the CT/NG Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the CT/NG Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the CT/NG Testing Market

A detailed market share analysis in the CT/NG Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the CT/NG Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the CT/NG Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the CT/NG Testing Market

A strategic analysis of the CT/NG Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the CT/NG Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Danaher Corporation, ELITech Group SAS, F. Hoffmann-La Roche Ltd., Geneproof A.S., Genetic Signatures Ltd., Goffin Molecular Technologies B.V., Hologic, Inc., Meridian Bioscience Inc., Microbiologics, Inc., Molbio Diagnostics Pvt. Ltd., Operon S.A., PerkinElmer Inc., QIAGEN N.V., Sansure Biotech Inc., Seegene, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tianlong Technology Co., Ltd., Vircell S.L., and Visby Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the CT/NG Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Assays & Kits and Instruments & Analyzers.
  • Based on Testing Type, market is studied across Lab Tests and PoC Tests.
  • Based on Technology, market is studied across Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology, and Polymerase Chain Reaction.
  • Based on End User, market is studied across Clinical Laboratories and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of STIs worldwide
      • 5.1.1.2. Growing awareness about the consequences of untreated infections
      • 5.1.1.3. Rising need for point-of-care (POC) testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with advanced diagnostic equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives for promoting sexual health education
      • 5.1.3.2. Integration of automation systems to enhance workflow efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Emergence of antibiotic-resistant strains by CT/NG testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rapid adoption of instruments and analyzers for providing consistent results
    • 5.2.2. Testing Type: Gaining popularity of PoC tests for CT/NG
    • 5.2.3. Technology: Advancing Polymerase Chain Reaction (PCR)-based CT/NG testing for prioritizing accuracy over cost and speed
    • 5.2.4. End User: Popularity of point-of-care testing for hospital and clinic settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. CT/NG Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Assays & Kits
  • 6.3. Instruments & Analyzers

7. CT/NG Testing Market, by Testing Type

  • 7.1. Introduction
  • 7.2. Lab Tests
  • 7.3. PoC Tests

8. CT/NG Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Immunodiagnostics
  • 8.3. Isothermal Nucleic Acid Amplification Technology
  • 8.4. Polymerase Chain Reaction

9. CT/NG Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals & Clinics

10. Americas CT/NG Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CT/NG Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CT/NG Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally
    • 13.3.2. Bio-Rad Launches Exact Diagnostics CT/NG, STI Run Controls
    • 13.3.3. Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Becton, Dickinson and Company
  • 3. Binx Health, Inc.
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bioneer Corporation
  • 6. Danaher Corporation
  • 7. ELITech Group SAS
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Geneproof A.S.
  • 10. Genetic Signatures Ltd.
  • 11. Goffin Molecular Technologies B.V.
  • 12. Hologic, Inc.
  • 13. Meridian Bioscience Inc.
  • 14. Microbiologics, Inc.
  • 15. Molbio Diagnostics Pvt. Ltd.
  • 16. Operon S.A.
  • 17. PerkinElmer Inc.
  • 18. QIAGEN N.V.
  • 19. Sansure Biotech Inc.
  • 20. Seegene, Inc.
  • 21. Siemens Healthineers AG
  • 22. Thermo Fisher Scientific Inc.
  • 23. Tianlong Technology Co., Ltd.
  • 24. Vircell S.L.
  • 25. Visby Medical, Inc.

LIST OF FIGURES

  • FIGURE 1. CT/NG TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CT/NG TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CT/NG TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CT/NG TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CT/NG TESTING MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CT/NG TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CT/NG TESTING MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CT/NG TESTING MARKET SIZE, BY POC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CT/NG TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CT/NG TESTING MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CT/NG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CT/NG TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 189. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023